Replay available

Neuropace, Inc. (NPCE) Q3 2025 Earnings Call

Neuropace, Inc. (NASDAQ: NPCE) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Tue, November 4, 2025 at 4:30 PMendedReplay
Neuropace, Inc. (NPCE) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Scott Schaefer

Head of Investor Relations

Joel Becker

Chief Executive Officer

Patrick Williams

Chief Financial Officer

Rohan Patel

Analyst, J.P. Morgan

Priya Sachdeva

Analyst, UBS Financial

Mike Kratky

Analyst, Lee Rink Partners

Frank DeKinnen

Analyst, Lake Street Capital Markets

Paige Chamberlain

Analyst, Wolf Research

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. My name is Colby, and I'll be your conference operator today. At this time, I would like to welcome you to the NeuroPace Q3 earnings call. All lines have been placed on mute to prevent any background noise, and after the speaker's remarks, there will be a question and answer session. If you'd like to ask a question at that time, please press star, then the number one on your telephone keypad. If you'd like to withdraw your question at any time, please press star one again. Thank you. I would now like to turn the call over to Scott Schaefer, head of investor of NeuroSpace. Please go ahead. Thank you, operator, and welcome to NeuroPace's third quarter 2025 earnings conference call. Our agenda begins with Joel Becker, NeuroPace's chief executive officer, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Patrick Williams, our chief financial officer. Following our prepared remarks, we will open the call up for your questions. At that time, we ask the analysts to limit themselves to one question and one follow-up question each so we can provide an opportunity for everyone participating today. Let's quickly review our safe harbor statement. Some of the statements we will make on today's call may constitute forward-looking statements. These statements reflect management's intentions, beliefs, and expectations about future events, strategies, products, regulatory and operating plans, and performance. All forward-looking statements included on this call are made as of the date hereof based on information currently available to NeuroPACE, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in th...

More from Neuropace, Inc.